HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.

Abstract
The role of tolerance was investigated in the prophylaxis of Staphylococcus aureus endocarditis with cloxacillin in rats. The effect of a single dose of 500 mg/kg, two 80 mg/kg doses 3 h apart, and a single dose of 80 mg/kg, alone or in combination with a single dose of 4 mg of gentamicin/kg, were compared for a tolerant strain of S. aureus and its isogenic nontolerant variant. At all dosages, cloxacillin was significantly less effective in preventing endocarditis with the tolerant strain than with the nontolerant variant. With the high dose of cloxacillin or two successive lower doses, nearly complete protection could be obtained against the nontolerant strain. However, for the tolerant strain, only the combination of cloxacillin and gentamicin afforded almost complete protection. For the tolerant strain, no serum bactericidal activity was found at the time of bacterial challenge after an injection of any dose of cloxacillin. These results suggest that the in vitro phenomenon of tolerance may have relevance in vivo.
AuthorsG P Voorn, J Thompson, W H Goessens, W Schmall-Bauer, P H Broeders, M F Michel
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 166 Issue 1 Pg. 169-73 (Jul 1992) ISSN: 0022-1899 [Print] United States
PMID1607692 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gentamicins
  • Cloxacillin
Topics
  • Animals
  • Cloxacillin (administration & dosage, pharmacology, therapeutic use)
  • Drug Therapy, Combination (administration & dosage, pharmacology, therapeutic use)
  • Drug Tolerance
  • Endocarditis, Bacterial (drug therapy)
  • Female
  • Gentamicins (administration & dosage, therapeutic use)
  • Microbial Sensitivity Tests
  • Random Allocation
  • Rats
  • Serum Bactericidal Test
  • Staphylococcal Infections (drug therapy)
  • Staphylococcus aureus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: